Neurology
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Data Supplement
Right arrow Correspondence:
Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when Correspondence are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Hart, R. G.
Right arrow Articles by Bailey, R. D.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Hart, R. G.
Right arrow Articles by Bailey, R. D.
Related Collections
Right arrow All Cerebrovascular disease/Stroke
Right arrow Infarction

Neurology 2002;59:977-982
© 2002 American Academy of Neurology
Views & Reviews

An assessment of guidelines for prevention of ischemic stroke

Robert G. Hart, MD and Renee D. Bailey, MD

From the Department of Medicine (Neurology), University of Texas Health Science Center, San Antonio.

Address correspondence and reprint requests to Dr. Robert G. Hart, Department of Medicine (Neurology), University of Texas Health Science Center, MSC 7883, 7703 Floyd Curl Dr., San Antonio, TX 78229-3900; e-mail: hartr{at}uthscsa.edu

Objective: To compare methods and key management recommendations from recent stroke prevention guidelines.

Methods: Systematic review of guidelines for prevention of ischemic stroke published in English between 1996 and 2001 was conducted, and recommendations were independently abstracted and compared.

Results: Among 22 stroke prevention guidelines, information was provided about panel selection in 24%, funding source in 36%, consensus methods in 33%, and quantitative risk/benefit estimates in 38%. Eleven recommended anticoagulation for patients with atrial fibrillation at high risk for stroke, but eight different sets of criteria to identify high-risk patients were proposed. Recommendations regarding carotid endarterectomy for asymptomatic stenosis varied from general endorsement in a setting of low perioperative risk to routinely withholding surgery. All nine relevant guidelines endorsed aspirin in dosages between 50 and 325 mg/day for initial antiplatelet therapy following cerebral ischemia; six also suggested other antiplatelet agents as options for initial therapy.

Conclusions: Current stroke prevention guidelines do not provide adequate methodologic information to permit assessment of their quality, potential bias, and clinical applicability. Management recommendations are relatively consistent but differ in several important areas.




This article has been cited by other articles:


Home page
 ChestHome page
D. E. Singer, G. W. Albers, J. E. Dalen, M. C. Fang, A. S. Go, J. L. Halperin, G. Y. H. Lip, and W. J. Manning
Antithrombotic Therapy in Atrial Fibrillation: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition)
Chest, June 1, 2008; 133(6_suppl): 546S - 592S.
[Abstract] [Full Text] [PDF]

Home page
 StrokeHome page
R. Hart
American Stroke Association Guideline Policies
Stroke, August 1, 2006; 37(8): 1965 - 1965.
[Full Text] [PDF]

Home page
 Int J Qual Health CareHome page
B. Fervers, J. S. Burgers, M. C. Haugh, J. Latreille, N. Mlika-Cabanne, L. Paquet, M. Coulombe, M. Poirier, and B. Burnand
Adaptation of clinical guidelines: literature review and proposition for a framework and procedure.
Int. J. Qual. Health Care, June 1, 2006; 18(3): 167 - 176.
[Abstract] [Full Text] [PDF]

Home page
 Int J Qual Health CareHome page
I. P. Bridevaux, A.-M. Silaghi, J.-P. Vader, F. Froehlich, J.-J. Gonvers, and B. Burnand
Appropriateness of colorectal cancer screening: appraisal of evidence by experts
Int. J. Qual. Health Care, June 1, 2006; 18(3): 177 - 182.
[Abstract] [Full Text] [PDF]

Home page
 Med Decis MakingHome page
M. Man-Son-Hing, B. F. Gage, A. A. Montgomery, A. Howitt, R. Thomson, P. J. Devereaux, J. Protheroe, T. Fahey, D. Armstrong, and A. Laupacis
Preference-Based Antithrombotic Therapy in Atrial Fibrillation: Implications for Clinical Decision Making
Med Decis Making, September 1, 2005; 25(5): 548 - 559.
[Abstract] [PDF]

Home page
 ChestHome page
D. E. Singer, G. W. Albers, J. E. Dalen, A. S. Go, J. L. Halperin, and W. J. Manning
Antithrombotic Therapy in Atrial Fibrillation: The Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy
Chest, September 1, 2004; 126(3_suppl): 429S - 456S.
[Abstract] [Full Text] [PDF]

Home page
 Int J Qual Health CareHome page
P. J. Saturno, F. Medina, F. Valera, J. Montilla, P. Escolar, and J. J. Gascon
Validity and reliability of guidelines for neck pain treatment in primary health care. A nationwide empirical analysis in Spain
Int. J. Qual. Health Care, December 1, 2003; 15(6): 487 - 493.
[Abstract] [Full Text] [PDF]

Home page
 NeurologyHome page
M.A. Whelen, T.O. Crawford, A. Comi, J.M. Freeman, E.H. Kossoff, H. Singer, E.P.G. Vining, K. Yohay, M. Shevell, S. Ashwal, et al.
Practice parameter: Evaluation of the child with global developmental delay
Neurology, November 11, 2003; 61(9): 1315 - 1316.
[Full Text] [PDF]

Home page
 NeurologyHome page
G. M. Franklin and C. A. Zahn
AAN clinical practice guidelines: Above the fray
Neurology, October 8, 2002; 59(7): 975 - 976.
[Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2002 by AAN Enterprises, Inc.